课题基金 / 基金详情

INSPEIR: International Study for the Prevention of Dementia with Incretin-based drugs

INSPEIR: International Study for the Prevention of Dementia with Incretin-based drugs
INSPEIR：使用肠促胰岛素药物预防痴呆症的国际研究
批准号：
452164
负责人：
Renoux Christel
金额：
$18.39万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-09-01 至 2024-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=452164&lang=en
关键词：
Cohort Study Dementia Electronic Medical Records Incretin-Based Drugs Pharmacoepidemiology

项目摘要

项目成果

Renoux Christel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Patients with type 2 diabetes (high blood sugar) have a nearly two-fold increased risk of dementia. However, it is uncertain whether lowering blood sugar can help prevent dementia in patients with diabetes. Some antidiabetic drugs named incretin-based dru
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dihydropyridines for the prevention of dementia among patients with hypertension
The Use of Incretin-Based Drugs and SGLT-2 Inhibitors for the Prevention of Parkinson's Disease Among Patients with Type 2 Diabetes
Gabapentinoids and the risk of severe respiratory events in patients with chronic obstructive pulmonary disease.
Gabapentinoids and the risk of severe respiratory events in patients with chronic obstructive pulmonary disease
海外基金